BioCentury
ARTICLE | Company News

Radient Pharmaceuticals, University of Florida deal

January 31, 2011 8:00 AM UTC

Radient's subsidiary NuVax Therapeutics Inc. received exclusive, worldwide rights to use and commercialize four patented immune-gene therapy tools and systems from the university. NuVax plans to use t...